Open-Label Extension Study of Flibanserin in Women with Hypoactive Sexual Desire Disorder

Journal of Sexual Medicine

Volumn 9, Issue 12, 2012, Pages 3180-3188

  Jayne, Christopher ^a   Simon, James A ^b   Taylor, Leslie V ^c   Kimura, Toshio ^d   Lesko, Lynna M ^d,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Dean Foundation for Health Research and Education   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e Windwood Phama Consulting   (United States)

Author keywords

Desire; Flibanserin; HSDD; Hypoactive sexual desire disorder; Safety; Sexual function

Indexed keywords

FLIBANSERIN; PLACEBO;

ADULT; ARTICLE; BEDTIME DOSAGE; CONTROLLED STUDY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MAJOR CLINICAL STUDY; NAUSEA; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHINOPHARYNGITIS; SCORING SYSTEM; SEDATION; SIDE EFFECT; SINUSITIS; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 84870622539     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02942.x     Document Type: Article

References (24)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Text revision. Washington: American Psychiatric Press; 2000:1-943.
2. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-60.
3. Bachmann G. Female sexuality and sexual dysfunction: Are we stuck on the learning curve? J Sex Med 2006;3:639-45.
4. Rosen RC, Maserejian NN, Connor MK, Krychman ML, Brown CS, Goldstein I. Characteristics of premenopausal and postmenopausal women with acquired, generalized Hypoactive Sexual Desire Disorder: The Hypoactive Sexual Desire Disorder Registry for women. Menopause 2012;19:396-405.
5. Clayton AH, Dennerstein L, Pyke R, Sand M. Flibanserin: A potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. Womens Health (Lond Engl) 2010;6:639-53.
6. Allers KA, Dremencov E, Ceci A, Flik G, Ferger B, Cremers TI, Ittrich C, Sommer B. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: A microdialysis study. J Sex Med 2010;7:1757-67.
7. Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S. Pharmacology of flibanserin. CNS Drug Rev 2002;8:117-42.
8. Marazziti D, Palego L, Giromella A, Mazzoni MR, Borsini F, Mayer N, Naccarato AG, Lucacchini A, Cassano GB. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. Int J Neuropsychopharmacol 2002;5:131-40.
9. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in Hypoactive Sexual Desire Disorder. J Sex Med 2011;8:15-27.
10. DeRogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M, Jr., Wunderlich G, Pyke R. Treatment of Hypoactive Sexual Desire Disorder in premenopausal women: Efficacy of flibanserin in the VIOLET study. J Sex Med 2012;9:1074-85.
11. Katz M, DeRogatis LR, Ackeman R, Hedges P, Lesko L, Garcia M, Pyke R, Sand M. Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American premenopausal women: Results of the BEGONIA trial. J Sex Med 2011;8:153.
12. Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Jr., Lesko L, Pyke R. Treatment of Hypoactive Sexual Desire Disorder in premenopausal women: Efficacy of flibanserin in the DAISY study. J Sex Med 2012;9:793-804.
13. Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): Results from a randomized withdrawal trial. J Sex Med 2011;8:3160-70.
14. Clayton A, Jayne C, Jacobs M, Kimura T, Pyke R, Lewis-D'Agostino D. Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American premenopausal women: Results from the DAHLIA trial. J Sex Med 2009;6(suppl 5):408.
15. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72.
16. Beck AT, Steer RA, Brown GK. Beck depression inventory: Manual. 2nd edition. San Antonio: The Psychological Corporation; 1996:1-38.
17. Beck AT, Steer RA. Beck scale for suicide ideation. San Antonio: The Psychological Corporation; 1993:1-24.
18. DeRogatis L, Pyke R, McCormack J, Hunter A, Harding G. Does the Female Sexual Distress Scale-Revised cover the feelings of women with HSDD? J Sex Med 2011;8:2810-5.
19. DeRogatis LR, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with Hypoactive Sexual Desire Disorder. J Sex Med 2008;5:357-64.
20. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with Female Orgasmic Disorder and in women with Hypoactive Sexual Desire Disorder. J Sex Marital Ther 2003;29:39-46.
21. Revicki DA, Margolis MK, Bush EN, DeRogatis LR, Hanes V. Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with Hypoactive Sexual Desire Disorder. J Sex Med 2011;8:2237-45.
22. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R, Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
23. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
24. Gerstenberger EP, Rosen RC, Brewer JV, Meston CM, Brotto LA, Wiegel M, Sand M. Sexual Desire and the Female Sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without Hypoactive Sexual Desire Disorder. J Sex Med 2010;7:3096-103.